Basaglar

Generic name: Insulin Glargine
Brand names: Basaglar KwikPen
Drug class: Insulin

Usage of Basaglar

Basaglar is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours. Insulin is a hormone that works by lowering levels of Glucose (sugar) in the blood.

Basaglar is used to improve blood sugar control in adults and children with diabetes mellitus.

Basaglar, is for use in adults with type 1 or 2 diabetes and in children at least 6 years old with type 1 diabetes (not type 2).

For type 1 diabetes, Basaglar KwikPen is used together with a short-acting insulin given before meals.

Basaglar side effects

Get emergency medical help if you have any signs of an allergic Reaction to Basaglar: redness or swelling where an injection was given, itchy skin rash over the entire body, trouble breathing, fast heartbeats, feeling like you might pass out, or swelling in your tongue or throat.

Call your doctor at once if you have:

  • rapid weight gain, swelling in your feet or ankles;
  • shortness of breath; or
  • low blood potassium - leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling.

    • Common Basaglar side effects may include:

  • low blood sugar;
  • swelling, weight gain;
  • allergic reaction, itching, rash; or
  • thickening or hollowing of the skin where you injected the medicine.

    • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Basaglar

    You should not use Basaglar KwikPen if you are allergic to insulin, or if you are having an episode of hypoglycemia (low blood sugar) or diabetic ketoacidosis (call your doctor for treatment).

    Basaglar KwikPen is not approved for use by anyone younger than 6 years old, and some brands are for use only in adults. Do not use this medicine to treat type 2 diabetes in a child of any age.

    To make sure Basaglar is safe for you, tell your doctor if you have:

  • liver or kidney disease; or
  • heart failure or other heart problems.

    • Tell your doctor if you also take pioglitazone or rosiglitazone (sometimes contained in combinations with Glimepiride or metformin). Taking certain oral diabetes medicines while you are using insulin may increase your risk of serious heart problems.

    Tell your doctor if you are pregnant or breastfeeding.

    Follow your doctor's instructions about using this medicine if you are pregnant or you become pregnant. Controlling diabetes is very important during pregnancy.

    Relate drugs

    How to use Basaglar

    Use Basaglar exactly as prescribed by your doctor. Follow all directions on your prescription label. Do not use Basaglar in larger or smaller amounts or for longer than recommended.

    Read all patient information, medication guides, and instruction sheets provided to you. Ask your doctor or pharmacist if you have any questions.

    The Toujeo brand of Insulin glargine contains 3 times as much insulin per milliliter (mL) as the Basaglar brand. There are 300 units of insulin in 1 mL of Toujeo, and 100 units in 1 mL of Basaglar.

    If there are any changes in the brand, strength, or type of insulin you use, your dosage needs may change.

    Basaglar is injected under the skin. You will be shown how to use injections at home. Do not give yourself Basaglar if you do not understand how to use the injection and properly dispose of used needles and pens.

    Basaglar must not be given with an insulin pump, or mixed with other insulins. Do not inject Basaglar into a vein or a muscle.

    Do not inject this medicine into skin that is damaged, tender, bruised, pitted, thickened, scaly, or has a scar or hard lump.

    Basaglar is usually injected once per day at the SAMe time each day. You will be shown how to use injections at home. Do not give yourself this medicine if you do not understand how to use the injection and properly dispose of used needles and pens.

    Your care provider will show you the best places on your body to inject Basaglar. Use a different place each time you give an injection. Do not inject into the same place two times in a row.

    Use only the injection pen that comes with Basaglar KwikPen. Attach a new needle before each use. Do not transfer the insulin from the pen into a syringe.

    Never share an injection pen with another person, even if the needle has been changed. Sharing these devices can allow infections or disease to pass from one person to another.

    Use a disposable needle only once. Follow any state or local laws about throwing away used needles. Use a puncture-proof "sharps" disposal container (ask your pharmacist where to get one and how to throw it away). Keep this container out of the reach of children and pets.

    You may have low blood sugar (hypoglycemia) and feel very hungry, dizzy, irritable, confused, anxious, or shaky. To quickly treat hypoglycemia, eat or drink a fast-acting source of sugar (fruit juice, hard candy, crackers, raisins, or non-diet soda).

    Your doctor may prescribe a Glucagon injection kit in case you have severe hypoglycemia. Be sure your family or close friends know how to give you this injection in an emergency.

    Also watch for signs of high blood sugar (hyperglycemia) such as increased thirst or urination.

    Blood sugar levels can be affected by stress, illness, surgery, exercise, alcohol use, or skipping meals. Ask your doctor before changing your insulin dose or schedule.

    Basaglar is only part of a treatment program that may also include diet, exercise, weight control, blood sugar testing, and special medical care. Follow your doctor's instructions very closely.

    Keep Basaglar in its original container protected from heat and light. Do not freeze insulin or store it near the cooling element in a refrigerator. Throw away any insulin that has been frozen.

    Storing unopened (not in use) Basaglar KwikPen:

  • Refrigerate and use until the expiration date; or
  • if stored at room temperature (below 86 degrees Fahrenheit) , use within 28 days.

    • Storing opened (in use) Basaglar KwikPen:

  • Store the injection pen at room temperature (do not refrigerate) and use within 28 days.

    • Do not use the medicine if it looks cloudy, has changed colors, or has any particles in it. Call your pharmacist for new medicine.

    Wear a diabetes medical alert tag (or carry an ID card) in case of emergency. Any medical care provider who treats you should know that you have diabetes.

    Do not store an injection pen with the needle attached. Do not reuse a needle or syringe. Place them in a puncture-proof "sharps" container and dispose of it following state or local laws. Keep out of the reach of children and pets.

    Warnings

    Never share a Basaglar KwikPen with another person, even if the needle has been changed.

    You should not use Basaglar if you are having an episode of hypoglycemia (low blood sugar), or if you are in a state of diabetic ketoacidosis (call your doctor for treatment).

    Basaglar is only part of a complete program of treatment that may also include diet, exercise, weight control, foot care, eye care, dental care, and testing your blood sugar. Follow your diet, medication, and exercise routines very closely. Changing any of these factors can affect your blood sugar levels.

    Never share an injection pen, even if you changed the needle.

    What other drugs will affect Basaglar

    Many drugs can affect your blood sugar and may also affect Basaglar. Some medicines can increase or decrease the effects of insulin. Some drugs can also cause you to have fewer symptoms of hypoglycemia, making it harder to tell when your blood sugar is low. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use. Not all possible interactions are listed here.

    Popular FAQ

    Basaglar and Lantus both injections that contain insulin glargine, a long-acting form of insulin to help control blood sugar levels in type 1 and type 2 diabetes. Basaglar is considered a "follow-on" to Lantus but is not a biosimilar, according to the FDA. This means your doctor will need to write a prescription for one or the other as they cannot be substituted at the pharmacy. Continue reading

    Injecting insulin is not difficult, but it does take a bit of practice. There are three main sites where insulin can be injected: the stomach area except for a 2-inch circle around your navel, and the soft part of your waist, but not anywhere near your spine; the top and outer part of your thighs, but not your inner thighs or anywhere close to your knee; the outer back of your upper arm where there is a pocket of fatty tissue. Continue reading

    Insulins are usually grouped as fast-acting, intermediate-acting, or long-acting. Within these groups, they can be further classified as human insulin and human insulin analogs. An insulin analog is a human insulin that has one or two amino acids changed which affects how quickly it is absorbed after injection and how fast or slow it acts. Insulin analogs are usually given within 15 minutes of a meal or at the same time as food. Continue reading

    Toujeo may be given at any time of the day; however, once you have chosen a time, it is best to inject Toujeo within three hours of that time every day. If needed, you can change the time you administer Toujeo, just talk to your doctor about this. Continue reading

    Toujeo can stay out of the refrigerator for up to 56 days (8 weeks) according to the prescribing information written on 03/2023. If Toujeo if left out the refrigerator for more than 20 or 30 minutes, it should not be put back into the refrigerator. Continue reading

    Soliqua is a combination of insulin glargine plus lixisenatide, and Lantus only contains insulin glargine. Both are once-daily injections that are given under the skin (subcutaneously), but Soliqua can only be used in adults with type 2 diabetes whereas Lantus may be used to treat both type 1 and type 2 diabetes in adults and children over the age of six years. Both are made by Sanofi-Aventis. Continue reading

    Even though Toujeo is usually given once a day, some people may experience better blood sugar control if the dose is split and given twice a day (every 12 hours). Continue reading

    There are three pens in a box of Toujeo Solostar. There are two pens in a box of Toujeo Max Solostar. Continue reading

    Both Soliqua and Xultophy combine a long-acting insulin with a GLP-1 agonist: Xultopy brings together Tresiba (insulin degludec) and Victoza (liraglutide), while Soliqua combines Lantus (insulin glargine) with Adlyxin (lixisenatide). When used with diet and exercise for the treatment of type 2 diabetes, these agents can help you control blood sugar, insulin levels, and digestion and may help you lose weight. Continue reading

    Basaglar and Lantus both injections that contain insulin glargine, a long-acting form of insulin to help control blood sugar levels in type 1 and type 2 diabetes. Basaglar is considered a "follow-on" to Lantus but is not a biosimilar, according to the FDA. This means your doctor will need to write a prescription for one or the other as they cannot be substituted at the pharmacy. Continue reading

    Injecting insulin is not difficult, but it does take a bit of practice. There are three main sites where insulin can be injected: the stomach area except for a 2-inch circle around your navel, and the soft part of your waist, but not anywhere near your spine; the top and outer part of your thighs, but not your inner thighs or anywhere close to your knee; the outer back of your upper arm where there is a pocket of fatty tissue. Continue reading

    Toujeo may be given at any time of the day; however, once you have chosen a time, it is best to inject Toujeo within three hours of that time every day. If needed, you can change the time you administer Toujeo, just talk to your doctor about this. Continue reading

    Insulins are usually grouped as fast-acting, intermediate-acting, or long-acting. Within these groups, they can be further classified as human insulin and human insulin analogs. An insulin analog is a human insulin that has one or two amino acids changed which affects how quickly it is absorbed after injection and how fast or slow it acts. Insulin analogs are usually given within 15 minutes of a meal or at the same time as food. Continue reading

    Toujeo can stay out of the refrigerator for up to 56 days (8 weeks) according to the prescribing information written on 03/2023. If Toujeo if left out the refrigerator for more than 20 or 30 minutes, it should not be put back into the refrigerator. Continue reading

    Soliqua is a combination of insulin glargine plus lixisenatide, and Lantus only contains insulin glargine. Both are once-daily injections that are given under the skin (subcutaneously), but Soliqua can only be used in adults with type 2 diabetes whereas Lantus may be used to treat both type 1 and type 2 diabetes in adults and children over the age of six years. Both are made by Sanofi-Aventis. Continue reading

    Even though Toujeo is usually given once a day, some people may experience better blood sugar control if the dose is split and given twice a day (every 12 hours). Continue reading

    There are three pens in a box of Toujeo Solostar. There are two pens in a box of Toujeo Max Solostar. Continue reading

    Both Soliqua and Xultophy combine a long-acting insulin with a GLP-1 agonist: Xultopy brings together Tresiba (insulin degludec) and Victoza (liraglutide), while Soliqua combines Lantus (insulin glargine) with Adlyxin (lixisenatide). When used with diet and exercise for the treatment of type 2 diabetes, these agents can help you control blood sugar, insulin levels, and digestion and may help you lose weight. Continue reading

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords

    AI Assitant